UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound

Advanced drug delivery reviews, 2022-10, Vol.189, p.114517-114517, Article 114517

2022

Volltextzugriff (PDF)

ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression

Journal of neuroinflammation, 2022-02, Vol.19 (1), p.58-58, Article 58

2022

Volltextzugriff (PDF)

Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease

Journal of neuroinflammation, 2024-04, Vol.21 (1), p.90-90, Article 90

2024

Volltextzugriff (PDF)

Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion

PloS one, 2015-09, Vol.10 (9), p.e0137255-e0137255

2015

Volltextzugriff (PDF)

Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery

Stem cell reports, 2020-05, Vol.14 (5), p.924-939

2020

Volltextzugriff (PDF)

Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease

Journal of neuroinflammation, 2024-02, Vol.21 (1), p.50-50, Article 50

2024

Volltextzugriff (PDF)

A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery

Fluids and barriers of the CNS, 2024-08, Vol.21 (1), p.65-20, Article 65

2024

Volltextzugriff (PDF)

CuII(atsm) Attenuates Neuroinflammation

Frontiers in neuroscience, 2018-09, Vol.12, p.668-668

2018

Volltextzugriff (PDF)

Heparan Sulfate Proteoglycans as Drivers of Neural Progenitors Derived From Human Mesenchymal Stem Cells

Frontiers in molecular neuroscience, 2018-04, Vol.11, p.134-134

2018

Volltextzugriff (PDF)

Opportunities and challenges in delivering biologics for Alzheimer's disease by low-intensity ultrasound

Advanced drug delivery reviews, 2022-10, Vol.189, p.114517

2022

Volltextzugriff (PDF)

An Alzheimer's Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition

Cells (Basel, Switzerland), 2022-10, Vol.11 (20), p.3258

2022

Volltextzugriff (PDF)

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment

Biochimica et biophysica acta. Molecular basis of disease, 2024-02, Vol.1870 (2), p.166967-166967, Article 166967

2024

Volltextzugriff (PDF)

Data defining markers of human neural stem cell lineage potential

Data in brief, 2016-06, Vol.7, p.206-215

2016

Volltextzugriff (PDF)

CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications

Biochimie, 2024-08, Vol.223, p.147-157

2024

Volltextzugriff (PDF)

HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes

Journal of neuroscience research, 2020-08, Vol.98 (8), p.1619-1645

2020

Volltextzugriff (PDF)

Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound

Neurotherapeutics, 2024-01, Vol.21 (1), p.e00299-e00299, Article e00299

2024

Volltextzugriff (PDF)

Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination

Stem cell research, 2016-01, Vol.16 (1), p.92-104

2016

Volltextzugriff (PDF)

Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers

Biochimie, 2022-07, Vol.198, p.60-75

2022

Volltextzugriff (PDF)

A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies

Theranostics, 2022-01, Vol.12 (16), p.6826-6847

2022

Volltextzugriff (PDF)

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease

ACS chemical neuroscience, 2024-04, Vol.15 (7), p.1432-1455

2024

Volltextzugriff (PDF)

Differential Cytokine Responses of APOE3 and APOE4 Blood–brain Barrier Cell Types to SARS-CoV-2 Spike Proteins

Journal of neuroimmune pharmacology, 2024-05, Vol.19 (1), p.22-22, Article 22

2024

Volltextzugriff (PDF)

Investigation of lymphotoxin α genetic variants in migraine

Gene, 2013-01, Vol.512 (2), p.527-531

2013

Volltextzugriff (PDF)

Cu II (atsm) Attenuates Neuroinflammation

Frontiers in neuroscience, 2018, Vol.12, p.668

2018

Volltextzugriff (PDF)

Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion: e0137255

PloS one, 2015-09, Vol.10 (9)

2015

Volltextzugriff (PDF)

Proteoglycans, Neurogenesis and Stem Cell Differentiation

Proteoglycans in Stem Cells, 2021, Vol.9, p.111-152

2021

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(24)
Buchkapitel
(1)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound

ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression

Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease

Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion

Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery

Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease

A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery

CuII(atsm) Attenuates Neuroinflammation

Heparan Sulfate Proteoglycans as Drivers of Neural Progenitors Derived From Human Mesenchymal Stem Cells

Opportunities and challenges in delivering biologics for Alzheimer's disease by low-intensity ultrasound

An Alzheimer's Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment

Data defining markers of human neural stem cell lineage potential

CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications

HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes

Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound

Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination

Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers

A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease

Differential Cytokine Responses of APOE3 and APOE4 Blood–brain Barrier Cell Types to SARS-CoV-2 Spike Proteins

Investigation of lymphotoxin α genetic variants in migraine

Cu II (atsm) Attenuates Neuroinflammation

Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion: e0137255

Proteoglycans, Neurogenesis and Stem Cell Differentiation

Suchergebnisse filtern